Silencing of CXCR4 Inhibits Tumor Cell Proliferation and Neural Invasion in Human Hilar Cholangiocarcinoma.
- Author:
Xin Yu TAN
1
;
Shi CHANG
;
Wei LIU
;
Hui Huan TANG
Author Information
1. Department of Emergency, Xiangya Hospital, Central-South University, Changsha, China.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Hilar cholangiocarcinoma;
Neural invasion;
CXCR4;
RNA interference
- MeSH:
Aged;
Bile Duct Neoplasms/metabolism/*pathology;
Bile Ducts, Intrahepatic/metabolism/*pathology;
Case-Control Studies;
Cell Line, Tumor;
Cell Proliferation;
Cholangiocarcinoma/metabolism/*pathology;
Female;
Humans;
Immunohistochemistry;
Male;
Middle Aged;
Neoplasm Invasiveness;
Neoplasm Recurrence, Local/metabolism/pathology;
RNA Interference/*physiology;
RNA, Small Interfering/metabolism;
Receptors, CXCR4/antagonists & inhibitors/*metabolism;
Tumor Cells, Cultured
- From:Gut and Liver
2014;8(2):196-204
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: To evaluate the expression of CXC motif chemokine receptor 4 (CXCR4) in the tissues of patients with hilar cholangiocarcinoma (hilar-CCA) and to investigate the cell proliferation and frequency of neural invasion (NI) influenced by RNAi-mediated CXCR4 silencing. METHODS: An immunohistochemical technique was used to detect the expression of CXCR4 in 41 clinical tissues, including hilar-CCA, cholangitis, and normal bile duct tissues. The effects of small interference RNA (siRNA)-mediated CXCR4 silencing were detected in the hilar-CCA cell line QBC939. Cell proliferation was determined by MTT. Expression of CXCR4 was monitored by quantitative real time polymerase chain reaction and Western blot analysis. The NI ability of hilar-CCA cells was evaluated using a perineural cell and hilar-CCA cell coculture migration assay. RESULTS: The expression of CXCR4 was significantly induced in clinical hilar-CCA tissue. There was a positive correlation between the expression of CXCR4 and lymph node metastasis/NI in hilar-CCA patients (p<0.05). Silencing of CXCR4 in tumor cell lines by siRNA led to significantly decreased NI (p<0.05) and slightly decreased cell proliferation. CONCLUSIONS: CXCR4 is likely correlated with clinical recurrence of hilar-CCA. CXCR4 is involved in the invasion and proliferation of human hilar-CCA cell line QBC939, indicating that CXCR4 could be a promising therapeutic target for hilar-CCA.
